Skip to main content

Cerity Partners LLC

Position in NVS — Novartis AG

CIK 1566475 NEW YORK, NY

Position in NVS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$50,393,751
+$9,753,812 QoQ
Shares Held
329,910
+11.9% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 21.66984935285381.ToString("F0")% Shared 15.197174987117698.ToString("F0")% None 63.13297566002849.ToString("F0")%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Cerity Partners LLC holds $2,080,837,635 across 16 Drug Manufacturers - General names. NVS ranks #8 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVS
Novartis AG
This page
329,910 $50,393,751

All Filings in NVS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $50,393,751 329,910
2025-12-31 $40,639,939 294,770
2025-09-30 $42,663,139 332,682
2025-06-30 $40,992,742 338,755
2025-03-31 $37,610,342 337,373
2024-12-31 $30,213,684 310,489
2024-09-30 $36,287,429 315,488
2024-06-30 $28,664,993 269,256
2024-03-31 $27,778,534 287,176
2023-12-31 $25,020,466 247,801
2023-09-30 $19,292,895 189,406
2023-06-30 $23,004,755 227,973
2023-03-31 $20,656,484 224,527
2022-12-31 $6,190,460 68,237
2022-09-30 $3,029,834 39,861
2022-06-30 $3,272,917 38,719
2022-03-31 $2,102,051 23,955
2021-12-31 $1,996,940 22,830
2021-09-30 $1,052,753 12,873
2021-06-30 $1,237,761 13,566
2021-03-31 $1,271,002 14,869
2020-12-31 $1,577,830 16,709
2020-09-30 $1,520,843 17,489
2020-06-30 $1,445,477 16,550
2020-03-31 $1,550,802 18,809